Global Non-invasive Prenatal Diagnostics Market Size & Outlook

The global non-invasive prenatal diagnostics market size was estimated at USD 3,364.5 million in 2020 and is projected to reach USD 6,281.9 million by 2027, growing at a CAGR of 9.3% from 2021 to 2027.
Revenue, 2020 (US$M)
$3,364.5
Forecast, 2027 (US$M)
$6,281.9
CAGR, 2021 - 2027
9.3%
Report Coverage
Worldwide

Global non-invasive prenatal diagnostics market highlights

  • The global non-invasive prenatal diagnostics market generated a revenue of USD 3,364.5 million in 2020 and is expected to reach USD 6,281.9 million by 2027.
  • The market is expected to grow at a CAGR (2021 - 2027) of 9.3% by 2027.
  • In terms of segment, 13-24 weeks accounted for a revenue of USD 1,543.3 million in 2020.
  • 0-12 weeks is the most lucrative gestation period segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2020.
  • Country-wise, U.S. is expected to register the highest CAGR from 2021 to 2027.

Global data book summary

Market revenue in 2020USD 3,364.5 million
Market revenue in 2027USD 6,281.9 million
Growth rate9.3% (CAGR from 2020 to 2027)
Largest segment13-24 weeks
Fastest growing segment0-12 weeks
Historical data covered2015 - 2019
Base year for estimation2020
Forecast period covered2021 - 2027
Quantitative unitsRevenue in USD million
Market segmentation0-12 weeks, 13-24 weeks, 25-36 weeks

Other key industry trends

  • In terms of revenue, the North America accounted for 45.9% of the global non-invasive prenatal diagnostics market in 2020.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2027.
  • By country, U.S. is the fastest growing regional market and is projected to reach USD 2,403.1 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Non-invasive Prenatal Diagnostics Market Companies

Name Profile # Employees HQ Website
Medgene Labs View profile 11-50 Sioux Falls, South Dakota, United States, North America https://medgenelabs.com
CooperSurgical View profile 501-1000 Trumbull, Connecticut, United States, North America http://www.coopersurgical.com
Biora Therapeutics View profile 51-100 Carlsbad, California, United States, North America https://www.bioratherapeutics.com/
Centogene NV Ordinary Shares View profile 493 Am Strande 7, Rostock, MV, Germany, 18055 https://www.centogene.com
Roche View profile 10001+ Basel, Basel-Stadt, Switzerland, Europe http://www.roche.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Natera Inc View profile 3293 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 https://www.natera.com
Myriad Genetics Inc View profile 2700 320 Wakara Way, Salt Lake City, UT, United States, 84108 https://www.myriad.com
Eurofins Scientific SE View profile 61798 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 https://www.eurofins.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Quest Diagnostics Inc View profile 48000 500 Plaza Drive, Secaucus, NJ, United States, 07094 https://www.questdiagnostics.com

Global non-invasive prenatal diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive prenatal diagnostics market will help companies and investors design strategic landscapes.


13-24 weeks was the largest segment with a revenue share of 45.87% in 2020. Horizon Databook has segmented the Global non-invasive prenatal diagnostics market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2015 to 2027.


  • Global Non-invasive Prenatal Diagnostics Gestation Period Outlook (Revenue, USD Million, 2015-2027)
    • 0-12 weeks
    • 13-24 weeks
    • 25-36 weeks
  • Global Non-invasive Prenatal Diagnostics Risk Outlook (Revenue, USD Million, 2015-2027)
    • High & Average Risk
    • Low Risk
  • Global Non-invasive Prenatal Diagnostics Product Outlook (Revenue, USD Million, 2015-2027)
    • Ultrasound Detection
    • Biochemical Screening Tests
    • Cell-Free Dna in Maternal Plasma Tests

Reasons to subscribe to Global non-invasive prenatal diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global non-invasive prenatal diagnostics market databook

  • Our clientele includes a mix of non-invasive prenatal diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global non-invasive prenatal diagnostics market, including forecasts for subscribers. This global databook contains high-level insights into Global non-invasive prenatal diagnostics market from 2015 to 2027, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global noninvasive prenatal diagnostics market size, by regions, 2015-2027 (US$M)

Top 10 countries: Noninvasive prenatal diagnostics market size, 2020 (US$M)

Global noninvasive prenatal diagnostics market share, by gestation period, 2020 & 2027 (%, US$M)

Non-invasive prenatal diagnostics market: Opportunity assessment by country

Global non-invasive prenatal diagnostics market, by region, 2020 (US$M)

Global noninvasive prenatal diagnostics market size, by regions, 2015-2027 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online